General Information of Drug (ID: DMILD4U)

Drug Name
LRX712
Indication
Disease Entry ICD 11 Status REF
Osteoarthritis FA00-FA05 Phase 2 [1]
Cross-matching ID
TTD ID
DFV73I

References

1 ClinicalTrials.gov (NCT04097379) A Randomized, Placebo-controlled, Subject and Investigator Blinded Study Investigating the Safety, Tolerability and Preliminary Efficacy of 8-week Treatment With Intra-articular LRX712 to Regenerate Articular Cartilage in Patients With Mild/Moderate Knee Osteoarthritis. U.S.National Institutes of Health.